Sağlam et al32 showed that systemic administration of boric acid may reduce alveolar bone loss by affecting the receptor activator of nuclear factor kappa-B ligand (RANKL)/osteoprotegerin balance in periodontal disease in rats. The gene discussed is TNFSF11; the disease is periodontal disorder.